![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Telkom Indonesia Persero Tbk PT | TG:PTI | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.10 | 17.00 | 17.10 | 0.00 | 17:37:23 |
RNS Number:5049M Protherics PLC 19 June 2003 Not for release, publication or distribution in or into the United States, Canada, Australia or Japan Recommended Offer By WestLB Panmure Limited ("Panmure") On behalf of Protherics PLC ("Protherics") To acquire the whole of the issued and to be issued share capital of Enact Pharma plc ("Enact") Offer declared unconditional in all respects Panmure is pleased to announce on behalf of Protherics that all outstanding conditions have now been either satisfied or waived and, accordingly, that the Offer is unconditional in all respects. The Offer remains open for acceptances until further notice. The consideration to which accepting Enact Shareholders are entitled will be posted (i) in the case of acceptances received (complete in all respects) by 3.00 p.m. on 18th June, within 14 days of this date; or (ii) in the case of acceptances received (complete in all respects) after 3.00 p.m. on 18th June but while the Offer remains open, within 14 days of such receipt. At 3.00 p.m. on 18th June, valid acceptances of the Offer made by WestLB Panmure on behalf of Protherics had been received in respect of a total of 37,721,147 Enact Shares, representing approximately 89.37 per cent. of Enact's issued share capital. None of such acceptances have been received from persons acting in concert with Protherics. Prior to the commencement of the Offer, irrevocable undertakings to accept the Offer had been received in respect of, in aggregate, 11,612,830 Enact Shares, representing 27.5 per cent. of Enact's issued share capital. In addition, Protherics received a non-binding letter of intent to accept the Offer in respect of a further 10,004,277 Enact Shares representing 23.7 per cent. of Enact's issued share capital. Valid acceptances have been received in respect of all of the shares subject to these undertakings and the letter of intent and are included in the above total. Other than as set out above, neither Protherics nor any person acting, or deemed to be acting, in concert with it held any Enact Shares as at 1 May 2003, the day before the commencement of the Offer Period, or has acquired or agreed to acquire any Enact Shares (or rights over such shares) during the Offer Period. The Offer will remain open for acceptance until further notice. Upon Protherics receiving acceptances under the Offer in respect of, and or otherwise acquiring, 90 per cent. or more of the Enact shares to which the Offer relates, Protherics intends to apply the provisions of sections 428 to 430F of the Companies Act 1985 (as amended) to acquire compulsorily any Enact Shares in respect of which valid acceptances have not been received. Enact Shareholders who have not yet accepted the Offer are urged to complete and return their Form of Acceptance as soon as possible. As described in the Offer Document, Protherics intends to apply to OFEX for the cancellation of the trading in Enact Shares. Accordingly, the notice period of 20 business days has commenced and it is expected that the listing of Enact's shares will be cancelled on 10th July. Terms defined in the Offer Document dated 7 May 2003 have the same meaning in this press release unless the context otherwise requires. 19 June 2003 Protherics PLC Andrew Heath, Chief Executive 020 7246 9950 Barry Riley, Finance Director 01928 518000 WestLB Panmure Limited Juliet Thompson 020 7020 5462 Enact Pharma plc James Cooper 07740 835289 The Maitland Consultancy Brian Hudspith 020 7379 5151 Simone Cheetham WestLB Panmure Limited, which is regulated in the United Kingdom by The Financial Services Authority, is acting exclusively for Protherics in connection with the Offer and no-one else and will not be responsible to anyone other than Protherics for providing the protections afforded to customers of WestLB Panmure Limited, nor for giving advice in relation to the Offer. This information is provided by RNS The company news service from the London Stock Exchange END OUPBRGDLBXBGGXI
1 Year Telkom Indonesia Persero... Chart |
1 Month Telkom Indonesia Persero... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions